Top 10 Companies in Gene Synthesis Market: Trends, Growth Dynamics, and Forecast 2025–2031

Market Overview

Gene synthesis is revolutionizing biotechnology and life sciences through the artificial creation of DNA sequences without a natural template. It is widely used across research, pharmaceutical, agricultural, and industrial domains to produce customized genes with high accuracy and efficiency.

global Gene Synthesis market was valued at USD 576 million in 2023 and is projected to reach USD 1661 million by 2030, growing at a CAGR of 16.35% during 2024–2030. This exponential growth is being fueled by increased adoption in genomics, personalized medicine, and synthetic biology.

Regional Insights

North America Gene Synthesis market is expected to grow from USD 198.42 million in 2023 to USD 477 million by 2030, at a CAGR of 13.48%.
Asia-Pacific is projected to show the fastest growth, from USD 209.61 million in 2023 to USD 748.59 million by 2030, with a CAGR of 19.77%.
These developments are driven by investments in genomics infrastructure and rising demand for gene-based therapies and applications.

Get FREE Sample of this Report at https://www.intelmarketresearch.com/download-free-sample/502/gene-synthesis-market

What is Gene Synthesis?

Gene synthesis is a method of constructing specific DNA sequences from scratch by assembling nucleotides in a pre-defined order. It eliminates the need for template DNA, offering researchers the flexibility to create genetic materials tailored to their needs.

This technique plays a vital role in synthetic biology, gene therapy, diagnostics, vaccine development, agricultural engineering, and more. It enables precise design of biological pathways, development of personalized drugs, and genetically modified organisms with enhanced traits.

Top 10 Companies in Gene Synthesis

GenScript
Thermo Scientific
IDT (Integrated DNA Technologies)
Eurofins Genomics
DNA 2.0 (ATUM)
BBI
Azenta Life Sciences
SBS Genetech
Bio Basic
Twist Bioscience

These leading companies accounted for around 72.41% of total market revenue in 2023, offering a wide array of synthesis platforms, automation capabilities, and custom gene design services.

Market Segmentation

By Type

Below 1000 bp
1001–3000 bp
3001–5000 bp
Above 5000 bp

By Application

Commercial
Academic Research

Drivers Boosting Market Growth

Rising Demand for Personalized Medicine and Gene Therapy
Tailored treatments based on individual genetic makeup are fueling demand for synthetic gene technologies, including CRISPR-based gene therapies.
Rapid Growth in Synthetic Biology
Synthetic biology applications such as biofuels, synthetic enzymes, and artificial cells rely heavily on synthetic gene assembly.
Advancements in Gene Editing Tools
CRISPR-Cas9 and other gene-editing systems require precise DNA constructs, making gene synthesis integral to custom genome-editing projects.
Expanding Use in Agriculture and Industrial Biotechnology
Genetically modified crops and microorganisms designed for high-yield bio-production are boosting demand in agri-biotech and bioprocessing sectors.
Falling DNA Synthesis Costs
Technological improvements in high-throughput platforms are reducing costs, enhancing affordability for startups and research organizations.
Rising Genomics Research Funding
Public and private funding in genomics and life sciences globally is creating favorable conditions for market growth.

Key Market Restraints

High Initial Setup and Operational Costs
Advanced synthesis labs require significant capital and skilled workforce, limiting access for small organizations.
Ethical and Regulatory Scrutiny
Concerns around human germline editing, synthetic organisms, and bioterrorism risks are attracting stricter regulation.
Challenges in Long DNA Sequence Synthesis
Producing error-free, long-sequence genes remains a technical hurdle, slowing research timelines and increasing costs.
Preference for Alternative Gene Methods
Traditional gene cloning or naturally extracted sequences may be preferred for certain applications due to simplicity or regulatory familiarity.

Opportunities Driving Future Expansion

Integration of AI and Automation
Automation and artificial intelligence are enhancing speed, efficiency, and precision in designing and synthesizing custom DNA sequences.
Synthetic Vaccines and Biologics Development
Accelerated biologics development, as seen during the pandemic, is pushing demand for fast-turnaround gene synthesis.
Drug Discovery and High-Throughput Screening
Pharma companies are increasingly relying on synthetic DNA libraries for compound screening and drug target validation.
Agricultural Biotechnology Applications
Demand for bioengineered crops with higher yields, disease resistance, and sustainability is creating growth potential.
Emerging Markets and Infrastructure Growth
Countries across Asia-Pacific, Latin America, and Africa are expanding biotech infrastructure, presenting new opportunities.
Collaborations and Innovation Ecosystems
Partnerships between biotech firms, academic institutes, and tech startups are fostering innovation and scaling capabilities.

Challenges Facing the Industry

Data Security and Bioethics
Concerns over synthetic DNA misuse and biosecurity risks require robust policy and ethical safeguards.
Accuracy and Error-Free Synthesis
Ensuring high fidelity in longer sequences remains a bottleneck despite recent progress.
Global Regulatory Compliance
Diverse and complex regulations in different regions can increase time-to-market and operational costs.
Competitive Pressure
Intensifying competition is driving the need for cost-effective, differentiated solutions to maintain market share.
Public Acceptance Issues
Skepticism around genetic engineering could slow adoption in agriculture, food, and consumer health applications.